Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2005

Open Access 01-12-2005 | Research

Cancer history and other personal factors affect quality of life in patients with hepatitis C

Authors: Sara H Olson, Sandy Iyer, Jennifer Scott, Orry Erez, Shelby Samuel, Temima Markovits, Myron Schwartz, Charlene Toro, Maya Gambarin-Gelwan, Robert C Kurtz

Published in: Health and Quality of Life Outcomes | Issue 1/2005

Login to get access

Abstract

Background

Although patients with chronic hepatitis C (CHC) have been found to have reduced quality of life, little is known about how other characteristics affect their quality of life. The purpose of this study was to investigate the effect of other characteristics, including history of cancer, on quality of life in patients with CHC.

Methods

One hundred forty patients from clinics at three hospitals in New York City completed a detailed epidemiologic interview about demographic and lifestyle characteristics and the SF-36 measuring health-related quality of life. We compared results from our patients to normative data using t-tests of differences between means. We used multivariate analyses to determine other personal and health-related factors associated with quality of life outcomes.

Results

Compared to normative data, these patients had reduced quality of life, particularly on physical functioning. The summary Physical Component Score (PCS) was 45.4 ± 10.6 and the Mental Component Score (MCS) was 48.2 ± 11.1, vs norms of 50 ± 10.0; p-values were <0.0001 and <0.05, respectively. In multivariate analyses, the PCS was significantly lower among those with cancer history, ≥ 2 other chronic conditions, less education, low physical activity, and higher alanine aminotransferase (ALT) levels. Cancer was more important for men, while other chronic conditions were more important for women. On the MCS, history of depression, low physical activity, alcohol use, and female gender were independently associated with poorer scores.

Conclusion

Several health and lifestyle factors independently influence quality of life in CHC patients. Different factors are important for men and women.
Literature
1.
go back to reference Bayliss MS, Gandek B, Bungay LM, Sugano D, Hsu MA, Ware JE Jr: A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C. Qual Life Res 1998, 7: 39–55. 10.1023/A:1008884805251PubMedCrossRef Bayliss MS, Gandek B, Bungay LM, Sugano D, Hsu MA, Ware JE Jr: A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C. Qual Life Res 1998, 7: 39–55. 10.1023/A:1008884805251PubMedCrossRef
2.
go back to reference Bonkovsky HL, Woolley JM, the Consensus Interferon Study Group: Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. Hepatology 1999, 29: 264–270. 10.1002/hep.510290124PubMedCrossRef Bonkovsky HL, Woolley JM, the Consensus Interferon Study Group: Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. Hepatology 1999, 29: 264–270. 10.1002/hep.510290124PubMedCrossRef
3.
go back to reference Ware JE Jr, Bayliss MS, Mannocchia M, Davis GL: Health-related quality of life in chronic hepatitis C: Impact of disease and treatment response. Hepatology 1999, 30: 550–555. 10.1002/hep.510300203PubMedCrossRef Ware JE Jr, Bayliss MS, Mannocchia M, Davis GL: Health-related quality of life in chronic hepatitis C: Impact of disease and treatment response. Hepatology 1999, 30: 550–555. 10.1002/hep.510300203PubMedCrossRef
4.
go back to reference McHutchison JG, Ware JE Jr, Bayliss MS, Pianko S, Albrecht JK, Cort S, Yang I, Neary MP, Hepatitis Interventional Therapy Group: The effects of interferon alpha-2b in combination with ribavirin on health-related quality of life and work productivity. J Hepatol 2001, 34: 140–147. 10.1016/S0168-8278(00)00026-XPubMedCrossRef McHutchison JG, Ware JE Jr, Bayliss MS, Pianko S, Albrecht JK, Cort S, Yang I, Neary MP, Hepatitis Interventional Therapy Group: The effects of interferon alpha-2b in combination with ribavirin on health-related quality of life and work productivity. J Hepatol 2001, 34: 140–147. 10.1016/S0168-8278(00)00026-XPubMedCrossRef
5.
go back to reference Bernstein D, Kleinman L, Barker CM, Revicki DA, Green J: Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients. Hepatology 2002, 35: 704–708. 10.1053/jhep.2002.31311PubMedCrossRef Bernstein D, Kleinman L, Barker CM, Revicki DA, Green J: Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients. Hepatology 2002, 35: 704–708. 10.1053/jhep.2002.31311PubMedCrossRef
6.
go back to reference Rasenack J, Zeuzem S, Feinman SV, Heathcote EJ, Manns M, Yoshida EM, Swain MG, Gane E, Diago M, Revicki DA, Lin A, Wintfeld N, Green J: Peginterferon alpha-2a (40 kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]. Pharmacoeconomics 2003, 21: 341–349.PubMedCrossRef Rasenack J, Zeuzem S, Feinman SV, Heathcote EJ, Manns M, Yoshida EM, Swain MG, Gane E, Diago M, Revicki DA, Lin A, Wintfeld N, Green J: Peginterferon alpha-2a (40 kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]. Pharmacoeconomics 2003, 21: 341–349.PubMedCrossRef
7.
go back to reference Ware JE Jr, Kosinski M, Gandek B: SF-36® Health Survey. Manual and Interpretation Guide. Lincoln, RI: QualityMetric Inc; 2000. Ware JE Jr, Kosinski M, Gandek B: SF-36® Health Survey. Manual and Interpretation Guide. Lincoln, RI: QualityMetric Inc; 2000.
8.
go back to reference Ware JE Jr, Kosinski M: SF-36® Physical and Mental Health Summary Scales: A Manual for Users of Version 1. 2nd edition. Lincoln, RI: QualityMetric Inc; 2001. Ware JE Jr, Kosinski M: SF-36® Physical and Mental Health Summary Scales: A Manual for Users of Version 1. 2nd edition. Lincoln, RI: QualityMetric Inc; 2001.
10.
go back to reference Foster GR, Goldin RD, Thomas HC: Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998, 27: 209–212. 10.1002/hep.510270132PubMedCrossRef Foster GR, Goldin RD, Thomas HC: Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998, 27: 209–212. 10.1002/hep.510270132PubMedCrossRef
11.
go back to reference Hussain KB, Fontana RJ, Moyer CA, Su GL, Sneed-Pee N, Lok AS: Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C. Am J Gastroenterol 2001, 96: 2737–2744. 10.1111/j.1572-0241.2001.04133.xPubMedCrossRef Hussain KB, Fontana RJ, Moyer CA, Su GL, Sneed-Pee N, Lok AS: Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C. Am J Gastroenterol 2001, 96: 2737–2744. 10.1111/j.1572-0241.2001.04133.xPubMedCrossRef
12.
go back to reference Fontana RJ, Moyer CA, Sonnad S, Lok ASF, Sneed-Pee N, Walsh J, Klein S, Webster S: Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C. Am J Gastroenterol 2001, 96: 170–178. 10.1111/j.1572-0241.2001.03473.xPubMedCrossRef Fontana RJ, Moyer CA, Sonnad S, Lok ASF, Sneed-Pee N, Walsh J, Klein S, Webster S: Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C. Am J Gastroenterol 2001, 96: 170–178. 10.1111/j.1572-0241.2001.03473.xPubMedCrossRef
13.
go back to reference Gallegos-Orozco JF, Fuentes AP, Argueta JG, Perez-Pruna C, Hinojosa-Becerril C, Sixtos-Alonso MS, Cruz-Castellanos S, Gutierrez-Reyes G, Olivera-Martinez MA, Gutierrez-Ruiz MC, Kershenobich D: Health-related quality of life and depression in patients with chronic hepatitis C. Arch Med Res 2003, 34: 124–129. 10.1016/S0188-4409(03)00003-1PubMedCrossRef Gallegos-Orozco JF, Fuentes AP, Argueta JG, Perez-Pruna C, Hinojosa-Becerril C, Sixtos-Alonso MS, Cruz-Castellanos S, Gutierrez-Reyes G, Olivera-Martinez MA, Gutierrez-Ruiz MC, Kershenobich D: Health-related quality of life and depression in patients with chronic hepatitis C. Arch Med Res 2003, 34: 124–129. 10.1016/S0188-4409(03)00003-1PubMedCrossRef
14.
go back to reference Younossi ZM, Boparai N, Price LL, Kiwi ML, McCormick M, Guyatt G: Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol 2001, 96: 2199–2205. 10.1111/j.1572-0241.2001.03956.xPubMedCrossRef Younossi ZM, Boparai N, Price LL, Kiwi ML, McCormick M, Guyatt G: Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol 2001, 96: 2199–2205. 10.1111/j.1572-0241.2001.03956.xPubMedCrossRef
15.
go back to reference Miller ER, Hiller JE, Shaw DR: Quality of Life in HCV-infection: lack of association with ALT levels. Aust N Z J Public Health 2001, 25: 355–361.PubMedCrossRef Miller ER, Hiller JE, Shaw DR: Quality of Life in HCV-infection: lack of association with ALT levels. Aust N Z J Public Health 2001, 25: 355–361.PubMedCrossRef
16.
go back to reference Holzner B, Kemmler G, Cella D, De Paoli C, Meraner V, Kopp M, Greil R, Fleischhacker WW, Sperner-Unterweger B: Normative data for functional assessment of cancer therapy. Acta Oncol 2004, 43: 153–160. 10.1080/02841860310023453PubMedCrossRef Holzner B, Kemmler G, Cella D, De Paoli C, Meraner V, Kopp M, Greil R, Fleischhacker WW, Sperner-Unterweger B: Normative data for functional assessment of cancer therapy. Acta Oncol 2004, 43: 153–160. 10.1080/02841860310023453PubMedCrossRef
17.
go back to reference Holzner B, Kemmler G, Kopp M, Nguyen-Van-Tam D, Sperner-Unterweger B, Greil R: Quality of life of patients with chronic lymphocytic leukemia: Results of a longitudinal investigation over 1 yr. Eur J Haematol 2004, 72: 381–389. 10.1111/j.1600-0609.2004.00233.xPubMedCrossRef Holzner B, Kemmler G, Kopp M, Nguyen-Van-Tam D, Sperner-Unterweger B, Greil R: Quality of life of patients with chronic lymphocytic leukemia: Results of a longitudinal investigation over 1 yr. Eur J Haematol 2004, 72: 381–389. 10.1111/j.1600-0609.2004.00233.xPubMedCrossRef
18.
go back to reference Loge JH, Abrahamsen AF, Ekeberg O, Kaasa S: Reduced health-related quality of life among Hodgkin's disease survivors: A comparative study with general population norms. Ann Oncol 1999, 10: 71–77. 10.1023/A:1008315525997PubMedCrossRef Loge JH, Abrahamsen AF, Ekeberg O, Kaasa S: Reduced health-related quality of life among Hodgkin's disease survivors: A comparative study with general population norms. Ann Oncol 1999, 10: 71–77. 10.1023/A:1008315525997PubMedCrossRef
19.
go back to reference Kiss TL, Abdolell M, Jamal N, Minden MD, Lipton JH, Messner HA: Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. J Clin Oncol 2002, 20: 2334–2343. 10.1200/JCO.2002.06.077PubMedCrossRef Kiss TL, Abdolell M, Jamal N, Minden MD, Lipton JH, Messner HA: Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. J Clin Oncol 2002, 20: 2334–2343. 10.1200/JCO.2002.06.077PubMedCrossRef
20.
go back to reference Vacek PM, Winstead-Fry P, Secker-Walker RH, Hooper GJ: Factors influencing quality of life in breast cancer survivors. Qual Life Res 2003, 12: 527–527. 10.1023/A:1025098108717PubMedCrossRef Vacek PM, Winstead-Fry P, Secker-Walker RH, Hooper GJ: Factors influencing quality of life in breast cancer survivors. Qual Life Res 2003, 12: 527–527. 10.1023/A:1025098108717PubMedCrossRef
21.
go back to reference Wettergren L, Bjorkholm M, Axdorph U, Langius-Eklof A: Determinants of health-related quality of life in long-term survivors of Hodgkin's lymphoma. Qual Life Res 2004, 13: 1369–1379. 10.1023/B:QURE.0000040790.43372.69PubMedCrossRef Wettergren L, Bjorkholm M, Axdorph U, Langius-Eklof A: Determinants of health-related quality of life in long-term survivors of Hodgkin's lymphoma. Qual Life Res 2004, 13: 1369–1379. 10.1023/B:QURE.0000040790.43372.69PubMedCrossRef
22.
go back to reference Casso D, Buist DSM, Taplin S: Quality of life of 5–10 year breast cancer survivors diagnosed between age 40 and 49. Health Qual Life Outcomes 2004, 2: 25. 10.1186/1477-7525-2-25PubMedCentralPubMedCrossRef Casso D, Buist DSM, Taplin S: Quality of life of 5–10 year breast cancer survivors diagnosed between age 40 and 49. Health Qual Life Outcomes 2004, 2: 25. 10.1186/1477-7525-2-25PubMedCentralPubMedCrossRef
23.
go back to reference Joly F, Heron JF, Kalusinski L, Bottet P, Brune D, Allouache N, Mace-Lesec'h J, Couette JE, Peny J, Henry-Amar M: Quality of life in long-term survivors of testicular cancer: a population-based case-control study. J Clin Oncol 2002, 20: 73–80. 10.1200/JCO.20.1.73PubMedCrossRef Joly F, Heron JF, Kalusinski L, Bottet P, Brune D, Allouache N, Mace-Lesec'h J, Couette JE, Peny J, Henry-Amar M: Quality of life in long-term survivors of testicular cancer: a population-based case-control study. J Clin Oncol 2002, 20: 73–80. 10.1200/JCO.20.1.73PubMedCrossRef
24.
go back to reference Rudberg L, Nilsson S, Wikblad K: Health-related quality of life in survivors of testicular cancer 3 to 13 years after treatment. J Psychosoc Oncol 2000, 18: 19–31. 10.1300/J077v18n03_02CrossRef Rudberg L, Nilsson S, Wikblad K: Health-related quality of life in survivors of testicular cancer 3 to 13 years after treatment. J Psychosoc Oncol 2000, 18: 19–31. 10.1300/J077v18n03_02CrossRef
25.
go back to reference Hickman IJ, Jonsson JR, Prins JB, Ash S, Purdie DM, Clouston AD, Powell EE: Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut 2004, 53: 413–419. 10.1136/gut.2003.027581PubMedCentralPubMedCrossRef Hickman IJ, Jonsson JR, Prins JB, Ash S, Purdie DM, Clouston AD, Powell EE: Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut 2004, 53: 413–419. 10.1136/gut.2003.027581PubMedCentralPubMedCrossRef
Metadata
Title
Cancer history and other personal factors affect quality of life in patients with hepatitis C
Authors
Sara H Olson
Sandy Iyer
Jennifer Scott
Orry Erez
Shelby Samuel
Temima Markovits
Myron Schwartz
Charlene Toro
Maya Gambarin-Gelwan
Robert C Kurtz
Publication date
01-12-2005
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2005
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-3-39

Other articles of this Issue 1/2005

Health and Quality of Life Outcomes 1/2005 Go to the issue